1. Home
  2. VRTX vs SHOP Comparison

VRTX vs SHOP Comparison

Compare VRTX & SHOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
    SELLHOLDBUYas of 5 hours ago
  • SHOP
    SELLHOLDBUYas of 5 hours ago
  • Stock Information
  • Founded
  • VRTX 1989
  • SHOP 2004
  • Country
  • VRTX United States
  • SHOP Canada
  • Employees
  • VRTX N/A
  • SHOP N/A
  • Industry
  • VRTX EDP Services
  • SHOP Computer Software: Prepackaged Software
  • Sector
  • VRTX Technology
  • SHOP Technology
  • Exchange
  • VRTX Nasdaq
  • SHOP Nasdaq
  • Market Cap
  • VRTX 104.8B
  • SHOP 122.8B
  • IPO Year
  • VRTX 1991
  • SHOP 2015
  • Fundamental
  • Price
  • VRTX $486.92
  • SHOP $84.68
  • Analyst Decision
  • VRTX Buy
  • SHOP Buy
  • Analyst Count
  • VRTX 25
  • SHOP 33
  • Target Price
  • VRTX $508.09
  • SHOP $116.71
  • AVG Volume (30 Days)
  • VRTX 1.4M
  • SHOP 10.2M
  • Earning Date
  • VRTX 05-05-2025
  • SHOP 05-07-2025
  • Dividend Yield
  • VRTX N/A
  • SHOP N/A
  • EPS Growth
  • VRTX N/A
  • SHOP 1409.81
  • EPS
  • VRTX N/A
  • SHOP 1.55
  • Revenue
  • VRTX $11,020,100,000.00
  • SHOP $8,880,000,000.00
  • Revenue This Year
  • VRTX $10.65
  • SHOP $25.52
  • Revenue Next Year
  • VRTX $9.02
  • SHOP $20.89
  • P/E Ratio
  • VRTX N/A
  • SHOP $64.96
  • Revenue Growth
  • VRTX 11.66
  • SHOP 25.78
  • 52 Week Low
  • VRTX $377.85
  • SHOP $48.56
  • 52 Week High
  • VRTX $519.88
  • SHOP $129.38
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 48.33
  • SHOP 34.69
  • Support Level
  • VRTX $471.50
  • SHOP $89.24
  • Resistance Level
  • VRTX $491.93
  • SHOP $101.45
  • Average True Range (ATR)
  • VRTX 10.91
  • SHOP 5.53
  • MACD
  • VRTX -4.08
  • SHOP -0.56
  • Stochastic Oscillator
  • VRTX 38.42
  • SHOP -2.46

Stock Price Comparison Chart: VRTX vs SHOP

VRTX
SHOP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April050100150200250300350400450500550VRTX VS SHOP

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use